DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients treated on clinical trials

被引：0
|
作者：
Tran, Q. [1 ]
Upadhyaya, S. [2 ]
Billups, C. [1 ]
Onar-Thomas, A. [1 ]
Carey, S. [1 ]
Alom, M. [1 ]
Robinson, G. [1 ]
Ellison, D. [1 ]
Gajjar, A. [1 ]
Orr, B. [1 ]
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN USA
[2] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2023年 / 82卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
131
引用
收藏
页码：544 / 544
页数：1
相关论文
共 50 条
  • [1] DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
    Tran, Quynh T.
    Upadhyaya, Santhosh A.
    Billups, Catherine A.
    Onar-Thomas, Arzu
    Alom, Md. Zahangir
    Carey, Steven S.
    Robinson, Giles W.
    Ellison, David W.
    Gajjar, Amar
    Orr, Brent A.
    ACTA NEUROPATHOLOGICA, 2023, 146 (03) : 543 - 545
  • [2] DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
    Quynh T. Tran
    Santhosh A. Upadhyaya
    Catherine A. Billups
    Arzu Onar-Thomas
    Md. Zahangir Alom
    Steven S. Carey
    Giles W. Robinson
    David W. Ellison
    Amar Gajjar
    Brent A. Orr
    Acta Neuropathologica, 2023, 146 : 543 - 545
  • [3] ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
    Federico, Aniello
    Thomas, Christian
    Miskiewicz, Katarzyna
    Woltering, Niklas
    Zin, Francesca
    Nemes, Karolina
    Bison, Brigitte
    Johann, Pascal D.
    Hawes, Debra
    Bens, Susanne
    Kordes, Uwe
    Albrecht, Steffen
    Dohmen, Hildegard
    Hauser, Peter
    Keyvani, Kathy
    van Landeghem, Frank K. H.
    Lund, Eva Lobner
    Scheie, David
    Mawrin, Christian
    Monoranu, Camelia-Maria
    Ulhoi, Benedicte Parm
    Pietsch, Torsten
    Reinhard, Harald
    Riemenschneider, Markus J.
    Sehested, Astrid
    Sumerauer, David
    Siebert, Reiner
    Paulus, Werner
    Fruehwald, Michael C.
    Kool, Marcel
    Hasselblatt, Martin
    ACTA NEUROPATHOLOGICA, 2022, 143 (06) : 697 - 711
  • [4] ATRT–SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance
    Aniello Federico
    Christian Thomas
    Katarzyna Miskiewicz
    Niklas Woltering
    Francesca Zin
    Karolina Nemes
    Brigitte Bison
    Pascal D. Johann
    Debra Hawes
    Susanne Bens
    Uwe Kordes
    Steffen Albrecht
    Hildegard Dohmen
    Peter Hauser
    Kathy Keyvani
    Frank K. H. van Landeghem
    Eva Løbner Lund
    David Scheie
    Christian Mawrin
    Camelia-Maria Monoranu
    Benedicte Parm Ulhøi
    Torsten Pietsch
    Harald Reinhard
    Markus J. Riemenschneider
    Astrid Sehested
    David Sumerauer
    Reiner Siebert
    Werner Paulus
    Michael C. Frühwald
    Marcel Kool
    Martin Hasselblatt
    Acta Neuropathologica, 2022, 143 : 697 - 711
  • [5] Prognostic significance of promoter DNA methylation in patients with neuroblastoma
    Lau, Diana T.
    Hesson, Luke B.
    Norris, Murray D.
    Haber, Michelle
    Marshall, Glenn M.
    Ashton, Lesley J.
    CANCER RESEARCH, 2012, 72
  • [6] Prognostic Significance of Promoter DNA Methylation in Patients with Childhood Neuroblastoma
    Lau, Diana T.
    Hesson, Luke B.
    Norris, Murray D.
    Marshall, Glenn M.
    Haber, Michelle
    Ashton, Lesley J.
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5690 - 5700
  • [7] Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials
    Wojdacz, Tomasz K.
    Amarasinghe, Harindra E.
    Kadalayil, Latha
    Beattie, Alice
    Forster, Jade
    Blakemore, Stuart J.
    Parker, Helen
    Bryant, Dean
    Larrayoz, Marta
    Clifford, Ruth
    Robbe, Pauline
    Davis, Zadie A.
    Else, Monica
    Howard, Dena R.
    Stamatopoulos, Basile
    Steele, Andrew J.
    Rosenquist, Richard
    Collins, Andrew
    Pettitt, Andrew R.
    Hillmen, Peter
    Plass, Christoph
    Schuh, Anna
    Catovsky, Daniel
    Oscier, David G.
    Rose-Zerilli, Matthew J. J.
    Oakes, Christopher C.
    Strefford, Jonathan C.
    BLOOD ADVANCES, 2019, 3 (16) : 2474 - 2481
  • [8] The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials
    Said, R.
    Banchs, J.
    Wheler, J.
    Hess, K. R.
    Falchook, G.
    Fu, S.
    Naing, A.
    Hong, D.
    Piha-Paul, S.
    Ye, Y.
    Yeh, E.
    Wolff, R. A.
    Tsimberidou, A. M.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 276 - 282
  • [9] Prognostic Methylation Markers for Survival in Cytogenetically Normal AML Patients Treated on SWOG Trials
    Qu, Xiaoyu
    Othus, Megan
    Davison, Jerry
    Yan, Liying
    Estey, Elihu H.
    Radich, Jerry
    Erba, Harry P.
    Appelbaum, Frederick R.
    Fang, Min
    BLOOD, 2015, 126 (23)
  • [10] Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease.
    Van Neste, Leander
    Stewart, Grant
    Gaston, Sandra Marlene
    Grizzle, William E.
    Adams, George W.
    Kearney, Gary P.
    Epstein, Jonathan I.
    Harrison, David James
    Partin, Alan W.
    Van Criekinge, Wim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345